Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors

被引:0
|
作者
Obana, K
Yang, HW
Piao, HY
Taki, T
Hashizume, K
Hanada, R
Yamamoto, K
Tanaka, Y
Toyoda, Y
Takita, J
Tsuchida, Y
Hayashi, Y
机构
[1] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Pediat Surg, Bunkyo Ku, Tokyo 1138655, Japan
[3] Saitama Childrens Med Ctr, Div Hematol Oncol, Urawa, Saitama, Japan
[4] Kanagawa Childrens Med Ctr, Div Oncol, Kanagawa, Japan
[5] Gunma Childrens Med Ctr, Dept Pediat Surg, Gunma, Japan
关键词
p16; gene; p15; p14(ARF) gene; neuroblastoma; Ewing's sarcoma; rhabdomyosarcoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of the p16(INK4A) (p16), p15(INK4B) (p15), and p14(ARF) genes, located at 9p21, was examined in pediatric neuroblastoma (NB), Ewing's sarcoma (ES), and rhabdomyosarcoma (RMS). p16 expression was absent in 4 of 5 ESs, and 2 of these 4 cases died. p16 expression was reduced or absent in 10 of 12 RMSs, and 4 of these 10 cases died. These results suggested the possibility that p16 expression was associated with the progression of ES and RMS. There has been no previous report on p14(ARF) in NB. Our investigation might indicate that abnormal expression of the p16 and p14(ARF) was associated with a poor prognosis in NB, although in some cases of NB normal p16 and abnormal p14(ARF) expression was seen. These findings suggest an important role of P14(ARF) gene in the tumorigenesis of NB. The different incidence of expression of the p16, p15, and p14(ARF) genes in these 3 tumor types may reflect differences of the molecular process through which the 3 tumors develop. Our results suggest that abnormal expression of the p16 and/or p14(ARF) may be associated with a poor prognosis in these 3 tumors.
引用
收藏
页码:1151 / 1157
页数:7
相关论文
共 50 条
  • [21] p14ARF,9p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia
    Kusy, S
    Larsen, CJ
    Roche, J
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 1989 - 1994
  • [22] Expression of p16INK4A and p14ARF in hematological malignancies
    T Taniguchi
    N Chikatsu
    S Takahashi
    A Fujita
    K Uchimaru
    S Asano
    T Fujita
    T Motokura
    Leukemia, 1999, 13 : 1760 - 1769
  • [23] Expression of p16INK4A and p14ARF in hematological malignancies
    Taniguchi, T
    Chikatsu, N
    Takahashi, S
    Fujita, A
    Uchimaru, K
    Asano, S
    Fujita, T
    Motokura, T
    LEUKEMIA, 1999, 13 (11) : 1760 - 1769
  • [24] Overexpression of p16INK4A and p14ARF in haematological malignancies
    Lee, YK
    Park, JY
    Kang, HJ
    Cho, HC
    CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (04): : 233 - 237
  • [25] Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas
    Nishimine, M
    Nakamura, M
    Kishi, M
    Okamoto, M
    Shimada, K
    Ishida, E
    Kirita, T
    Konishi, N
    ONCOLOGY REPORTS, 2003, 10 (03) : 555 - 560
  • [26] Expression of p14ARF, p15INK4b, p16INK4a and skp2 increases during esophageal squamous cell cancer progression
    Bai, Peng
    Xiao, Xue
    Zou, Juan
    Cui, Lin
    Nguyen, Tri M. Bui
    Liu, Jinsong
    Xiao, Jianguo
    Chang, Bin
    Wu, Jin
    Wang, He
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (06) : 1026 - 1032
  • [27] Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias [Untersuchung der Tumorsuppressoren p16INK4a und p14ARF in Mundschleimhautleukoplakien]
    Nitsche M.
    Koy S.
    Mörz M.
    Koch R.
    Eckelt U.
    Mund-, Kiefer- und Gesichtschirurgie, 2007, 11 (6): : 317 - 326
  • [28] The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15INK4b/p16INK4a/p14ARF in patients with acute lymphoblastic leukemia
    Faderl, S
    Estrov, Z
    Kantarjian, HM
    Thomas, D
    Cortes, J
    Manshouri, T
    Chan, CC
    Hays, KJ
    Pierce, S
    Albitar, M
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1999, 5 (03) : 159 - 163
  • [29] P16INK4a and P15INK4b alterations in vulval and endometrial cancer
    Cheng, YZ
    Blackett, AD
    BRITISH JOURNAL OF CANCER, 2003, 88 : S35 - S35
  • [30] p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
    Paul Krimpenfort
    Annemieke IJpenberg
    Ji-Ying Song
    Martin van der Valk
    Martijn Nawijn
    John Zevenhoven
    Anton Berns
    Nature, 2007, 448 : 943 - 946